Scientific article

Démence à corps de Lewy : état de l’art et perspectives pour le clinicien

Published inRevue médicale suisse, vol. 19, no. 824, p. 810-813
Publication date2023

Dementia with Lewy bodies (DLB) is one of the most common causes of dementia, after Alzheimer's disease (AD) and vascular dementia. Its diagnosis remains a challenge for the clinician because of the variety of clinical presentations and comorbidities. The diagnosis is based on clinical criteria such as cognitive fluctuations, visual hallucinations, progressive cognitive impairment, Parkinsonian signs and REM sleep behavioral disorder. Although not specific, biomarkers are helpful for increasing the likelihood of LBD diagnosis and for differentiating LBD from other differential diagnoses such as Parkinson's disease with dementia and Alzheimer's disease. Clinicians should be aware of LBD clinical features and actively look for them in patients with cognitive symptoms, take into consideration the often-associated co-pathologies and to optimize patient's management.

Citation (ISO format)
STANCU, Patrick et al. Démence à corps de Lewy : état de l’art et perspectives pour le clinicien. In: Revue médicale suisse, 2023, vol. 19, n° 824, p. 810–813. doi: 10.53738/revmed.2023.19.824.810
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 07/01/2025
ISSN of the journal1660-9379

Technical informations

Creation01/16/2024 3:57:14 PM
First validation04/10/2024 7:34:42 AM
Update time04/10/2024 7:34:42 AM
Status update04/10/2024 7:34:42 AM
Last indexation05/06/2024 6:21:43 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack